Fu Gui
Affiliations: | 2012-2016 | School of Life Sciences, Xiamen University |
Google:
"Fu Gui"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Xianming DENG | grad student | 2012-2016 | School of Life Sciences, Xiamen University |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gui F, Jiang B, Jiang J, et al. (2024) Acute BRCAness Induction and AR Signaling Blockage through CDK12/7/9 Degradation Enhances PARP Inhibitor Sensitivity in Prostate Cancer. Biorxiv : the Preprint Server For Biology |
| Tsujino T, Takai T, Hinohara K, et al. (2023) CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. Nature Communications. 14: 252 |
| Zhang CS, Li M, Wang Y, et al. (2022) The aldolase inhibitor aldometanib mimics glucose starvation to activate lysosomal AMPK. Nature Metabolism |
| Miao C, Tsujino T, Takai T, et al. (2022) loss overrides PARP inhibitor sensitivity driven by loss in prostate cancer. Science Advances. 8: eabl9794 |
| Lu Y, Fan Z, Zhu SJ, et al. (2021) A new ALK inhibitor overcomes resistance to first- and second-generation inhibitors in NSCLC. Embo Molecular Medicine. e14296 |
| Li W, Ni H, Wu S, et al. (2020) Targeting RIPK3 oligomerization blocks necroptosis without inducing apoptosis. Febs Letters |
| Gui F, Jiang J, He Z, et al. (2019) A non-covalent inhibitor XMU-MP-3 overrides ibrutinib-resistant Btk mutation in B-cell malignancies. British Journal of Pharmacology |
| Jiang J, Gui F, He Z, et al. (2016) Targeting BRK-positive breast cancers with small molecule kinase inhibitors. Cancer Research |
| Wang Y, Qi S, Zhan Y, et al. (2015) Aspertetranones A-D, Putative Meroterpenoids from the Marine Algal-Associated Fungus Aspergillus sp. ZL0-1b14. Journal of Natural Products |